SEC Company Response from PAVmed Inc. (PAVM) (CIK 0001624326) (PAVM) — Jan 5, 2018
PAVmed Inc. (PAVM) (CIK 0001624326)
Date: Jan. 5, 2018 · CIK: 0001624326 · Accession: 0001493152-18-000226
AI Filing Summary & Sentiment
Reasoning
File numbers found in text: 333-222234
Letter
PAVMED INC.
One Grand Central Place
E.42 ND Street
Suite
New York, New York 10165
January 5, 2018
Securities and Exchange Commission
Division of Corporation Finance
Washington, DC 20549
Re: PAVmed Inc.
Registration Statement on Form S-1
Originally Filed December 21, 2017
File No. 333-222234
Ladies and Gentlemen:
Pursuant to Rule 461 promulgated under the Securities Act of 1933, as amended, PAVmed Inc. (the “Company”) hereby requests acceleration of the effectiveness of the above-referenced Registration Statement (File No. 333-222234), so that such Registration Statement will become effective at 4:30 p.m. Eastern Time on Monday, January 8, 2018, or as soon thereafter as practicable.
Sincerely,
PAVMED INC.
Show Raw Text
CORRESP
1
filename1.htm
PAVMED
INC.
One
Grand Central Place
60
E.42 ND Street
Suite
4600
New
York, New York 10165
January
5, 2018
Securities
and Exchange Commission
Division
of Corporation Finance
Washington,
DC 20549
Re:
PAVmed
Inc.
Registration
Statement on Form S-1
Originally
Filed December 21, 2017
File
No. 333-222234
Ladies
and Gentlemen:
Pursuant
to Rule 461 promulgated under the Securities Act of 1933, as amended, PAVmed Inc. (the “Company”) hereby
requests acceleration of the effectiveness of the above-referenced Registration Statement (File No. 333-222234), so that such
Registration Statement will become effective at 4:30 p.m. Eastern Time on Monday, January 8, 2018, or as soon thereafter as practicable.
Sincerely,
PAVMED INC.
By:
/s/
Lishan Aklog, M.D.
Name:
Lishan
Aklog, M.D.
Title:
Chairman
and Chief Executive Officer